Pharm-Rx Irinotecan HCL

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

USP Irinotecan Hydrochloride RS
USP Irinotecan Related Compound A RS (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3’,4’:6,7] indolizino[1,2-b]quinoline-3,14(4H,12H)-dione.
C₂₀H₁₆N₂O₅  364.35

USP Irinotecan Related Compound B RS (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione.
C₂₂H₂₀N₂O₅  392.40

USP Irinotecan Related Compound C RS 11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl (1,4′-bipiperidine)-1′carboxylate
hydrochloride.
C₃₂H₃₆N₄O₆· HCl  609.11

USP Irinotecan Related Compound D RS (R)-9-[(1,4’-Bipiperidine)-1’-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate.
C₃₃H₃₈N₄O₆· HCl · 3 H₂O  677.18

Preserve in tight, light-resistant containers, and store at controlled room temperature.